SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
Dated December 17, 2003
IMI International Medical Innovations Inc.
Commission File Number 1-31360
300-4211 Yonge Street
Toronto, Ontario M2P 2A9
CANADA
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F
Form 20-F X Form 40-F
--- ---
Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(1): ____
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of
a Form 6-K if submitted solely to provide an attached annual report to security
holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7): ____
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of
a Form 6-K if submitted to furnish a report or other document that the
registrant foreign private issuer must furnish and make public under the laws of
the jurisdiction in which the registrant is incorporated, domiciled or legally
organized (the registrant's "home country"), or under the rules of the home
country exchange on which the registrant's securities are traded, as long as the
report or other document is not a press release, is not required to be and has
not been distributed to the registrant's security holders, and, if discussing a
1
material event, has already been the subject of a Form 6-K submission or other
Commission filing on EDGAR. Indicate by check mark whether by furnishing the
information contained in this Form, the registrant is also thereby furnishing
the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934. Yes ____ No X If "Yes" is marked, indicate
below the file number assigned to the registrant in connection with Rule
12g3-2(b): 82- ________
2
IMI International Medical Innovations Inc.
Form 6-K
On December 17, 2003, the Registrant publicly disseminated a press
release announcing the results of a pivotal skin cholesterol study published
this week. The information contained in the press release is incorporated herein
by reference and filed as Exhibit 99 hereto.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.
IMI International Medical Innovations Inc.
By: /s/ Ronald G. Hosking
--------------------------
Ronald G. Hosking
Vice President and Chief Financial Officer
Date: December 17, 2003
4
EXHIBIT INDEX
Exhibit
Number Description
--------- ---------------
99 The Registrant's Press Release
Dated December 17, 2003
5